Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News Releases view all

    • News in Focus
        • Browse News Releases

        • All News Releases
        • All Public Company
        • English-only
        • News Releases Overview

        • Multimedia Gallery

        • All Multimedia
        • All Photos
        • All Videos
        • Multimedia Gallery Overview

        • Trending Topics

        • All Trending Topics
    • Business & Money
        • Auto & Transportation

        • Aerospace, Defense
        • Air Freight
        • Airlines & Aviation
        • Automotive
        • Maritime & Shipbuilding
        • Railroads and Intermodal Transportation
        • Supply Chain/Logistics
        • Transportation, Trucking & Railroad
        • Travel
        • Trucking and Road Transportation
        • Auto & Transportation Overview

        • View All Auto & Transportation

        • Business Technology

        • Blockchain
        • Broadcast Tech
        • Computer & Electronics
        • Computer Hardware
        • Computer Software
        • Data Analytics
        • Electronic Commerce
        • Electronic Components
        • Electronic Design Automation
        • Financial Technology
        • High Tech Security
        • Internet Technology
        • Nanotechnology
        • Networks
        • Peripherals
        • Semiconductors
        • Business Technology Overview

        • View All Business Technology

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Financial Services & Investing

        • Accounting News & Issues
        • Acquisitions, Mergers and Takeovers
        • Banking & Financial Services
        • Bankruptcy
        • Bond & Stock Ratings
        • Conference Call Announcements
        • Contracts
        • Cryptocurrency
        • Dividends
        • Earnings
        • Earnings Forecasts & Projections
        • Financing Agreements
        • Insurance
        • Investments Opinions
        • Joint Ventures
        • Mutual Funds
        • Private Placement
        • Real Estate
        • Restructuring & Recapitalization
        • Sales Reports
        • Shareholder Activism
        • Shareholder Meetings
        • Stock Offering
        • Stock Split
        • Venture Capital
        • Financial Services & Investing Overview

        • View All Financial Services & Investing

        • General Business

        • Awards
        • Commercial Real Estate
        • Corporate Expansion
        • Earnings
        • Environmental, Social and Governance (ESG)
        • Human Resource & Workforce Management
        • Licensing
        • New Products & Services
        • Obituaries
        • Outsourcing Businesses
        • Overseas Real Estate (non-US)
        • Personnel Announcements
        • Real Estate Transactions
        • Residential Real Estate
        • Small Business Services
        • Socially Responsible Investing
        • Surveys, Polls and Research
        • Trade Show News
        • General Business Overview

        • View All General Business

    • Science & Tech
        • Consumer Technology

        • Artificial Intelligence
        • Blockchain
        • Cloud Computing/Internet of Things
        • Computer Electronics
        • Computer Hardware
        • Computer Software
        • Consumer Electronics
        • Cryptocurrency
        • Data Analytics
        • Electronic Commerce
        • Electronic Gaming
        • Financial Technology
        • Mobile Entertainment
        • Multimedia & Internet
        • Peripherals
        • Social Media
        • STEM (Science, Tech, Engineering, Math)
        • Supply Chain/Logistics
        • Wireless Communications
        • Consumer Technology Overview

        • View All Consumer Technology

        • Energy & Natural Resources

        • Alternative Energies
        • Chemical
        • Electrical Utilities
        • Gas
        • General Manufacturing
        • Mining
        • Mining & Metals
        • Oil & Energy
        • Oil and Gas Discoveries
        • Utilities
        • Water Utilities
        • Energy & Natural Resources Overview

        • View All Energy & Natural Resources

        • Environ­ment

        • Conservation & Recycling
        • Environmental Issues
        • Environmental Policy
        • Environmental Products & Services
        • Green Technology
        • Natural Disasters
        • Environment Overview

        • View All Environ­ment

        • Heavy Industry & Manufacturing

        • Aerospace & Defense
        • Agriculture
        • Chemical
        • Construction & Building
        • General Manufacturing
        • HVAC (Heating, Ventilation and Air-Conditioning)
        • Machinery
        • Machine Tools, Metalworking and Metallurgy
        • Mining
        • Mining & Metals
        • Paper, Forest Products & Containers
        • Precious Metals
        • Textiles
        • Tobacco
        • Heavy Industry & Manufacturing Overview

        • View All Heavy Industry & Manufacturing

        • Telecomm­unications

        • Carriers and Services
        • Mobile Entertainment
        • Networks
        • Peripherals
        • Telecommunications Equipment
        • Telecommunications Industry
        • VoIP (Voice over Internet Protocol)
        • Wireless Communications
        • Telecommunications Overview

        • View All Telecomm­unications

    • Lifestyle & Health
        • Consumer Products & Retail

        • Animals & Pets
        • Beers, Wines and Spirits
        • Beverages
        • Bridal Services
        • Cannabis
        • Cosmetics and Personal Care
        • Fashion
        • Food & Beverages
        • Furniture and Furnishings
        • Home Improvement
        • Household, Consumer & Cosmetics
        • Household Products
        • Jewelry
        • Non-Alcoholic Beverages
        • Office Products
        • Organic Food
        • Product Recalls
        • Restaurants
        • Retail
        • Supermarkets
        • Toys
        • Consumer Products & Retail Overview

        • View All Consumer Products & Retail

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Health

        • Biometrics
        • Biotechnology
        • Clinical Trials & Medical Discoveries
        • Dentistry
        • FDA Approval
        • Fitness/Wellness
        • Health Care & Hospitals
        • Health Insurance
        • Infection Control
        • International Medical Approval
        • Medical Equipment
        • Medical Pharmaceuticals
        • Mental Health
        • Pharmaceuticals
        • Supplementary Medicine
        • Health Overview

        • View All Health

        • Sports

        • General Sports
        • Outdoors, Camping & Hiking
        • Sporting Events
        • Sports Equipment & Accessories
        • Sports Overview

        • View All Sports

        • Travel

        • Amusement Parks and Tourist Attractions
        • Gambling & Casinos
        • Hotels and Resorts
        • Leisure & Tourism
        • Outdoors, Camping & Hiking
        • Passenger Aviation
        • Travel Industry
        • Travel Overview

        • View All Travel

    • Policy & Public Interest
        • Policy & Public Interest

        • Advocacy Group Opinion
        • Animal Welfare
        • Congressional & Presidential Campaigns
        • Corporate Social Responsibility
        • Domestic Policy
        • Economic News, Trends, Analysis
        • Education
        • Environmental
        • European Government
        • FDA Approval
        • Federal and State Legislation
        • Federal Executive Branch & Agency
        • Foreign Policy & International Affairs
        • Homeland Security
        • Labor & Union
        • Legal Issues
        • Natural Disasters
        • Not For Profit
        • Patent Law
        • Public Safety
        • Trade Policy
        • U.S. State Policy
        • Policy & Public Interest Overview

        • View All Policy & Public Interest

    • People & Culture
        • People & Culture

        • Aboriginal, First Nations & Native American
        • African American
        • Asian American
        • Children
        • Diversity, Equity & Inclusion
        • Hispanic
        • Lesbian, Gay & Bisexual
        • Men's Interest
        • People with Disabilities
        • Religion
        • Senior Citizens
        • Veterans
        • Women
        • People & Culture Overview

        • View All People & Culture

    • Explore Our Platform
    • Plan Campaigns
    • Create with AI
    • Distribute Press Releases
    • Report Results
    • Amplify Content
    • All Products
    • General Inquiries
    • Editorial Bureaus
    • Partnerships
    • Media Inquiries
    • Worldwide Offices
    • Hamburger menu
    • PR Newswire: news distribution, targeting and monitoring
    • Send a Release
      • ALL CONTACT INFO
      • Contact Us

        888-776-0942
        from 8 AM - 10 PM ET

    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • News
    • Products
    • Contact
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • 3 News in Focus
      • 5 Business & Money
      • 5 Science & Tech
      • 5 Lifestyle & Health
      • 1 Policy & Public Interest
      • 1 People & Culture
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content
      • All Products
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      Close submenu (News in Focus) News in Focus
      • Browse News Releases
      • Multimedia Gallery
      • Trending Topics
      Close submenu (Business & Money) Business & Money
      • Auto & Transportation
      • Business Technology
      • Entertain­ment & Media
      • Financial Services & Investing
      • General Business
      Close submenu (Science & Tech) Science & Tech
      • Consumer Technology
      • Energy & Natural Resources
      • Environ­ment
      • Heavy Industry & Manufacturing
      • Telecomm­unications
      Close submenu (Lifestyle & Health) Lifestyle & Health
      • Consumer Products & Retail
      • Entertain­ment & Media
      • Health
      • Sports
      • Travel
      Close submenu (Policy & Public Interest) Policy & Public Interest
      • Policy & Public Interest
      Close submenu (People & Culture) People & Culture
      • People & Culture

      Ellomay Capital Reports Results for the Three and Nine Months Ended September 30, 2019


      News provided by

      Ellomay Capital Ltd

      Dec 31, 2019, 13:00 ET

      Share this article

      Share this article


      TEL-AVIV, Israel, Dec. 31, 2019 /PRNewswire/ -- Ellomay Capital Ltd. (NYSE American: ELLO) (TASE: ELLO) ("Ellomay" or the "Company"), a renewable energy and power generator and developer of renewable energy and power projects in Europe and Israel, today reported its unaudited financial results for the three and nine months ended September 30, 2019.

      Ran Fridrich, CEO and a board member of Ellomay commented: "During the nine month period ended September 30, 2019 the Company operated in accordance with its business plan, while executing an extensive development and investment plan. Project development expenses increased by approximately 32% compared to the same period last year. Equity attributed to shareholders of the Company increased by approximately 26% during the period. The Talasol project (300 MW) in Spain is progressing according to plan and construction of more than 50% was already completed. The project is currently expected to commence commercial operation in Q4 of 2020. In addition, the Company is promoting the development of 550 MW PV in Spain and Italy."

      Financial Highlights

      • Revenues were approximately €15.4 million for the nine months ended September 30, 2019, compared to approximately €13.9 million for the nine months ended September 30, 2018. The increase in revenues is mainly a result of the commencement of operations of the Company's waste-to-energy project in Oude Tonge, the Netherlands, in June 2018 and relatively higher levels of radiation in Italy during 2019 compared to 2018.
      • Operating expenses were approximately €5 million for the nine months ended September 30, 2019, compared to approximately €4.6 million for the nine months ended September 30, 2018. The increase in operating expenses is mainly attributable to additional operating expenses resulting from the commencement of operations at the Company's waste-to-energy project in Oude Tonge, the Netherlands. Depreciation expenses were approximately €4.7 million for the nine months ended September 30, 2019, compared to approximately €4.4 million for the nine months ended September 30, 2018.
      • Project development costs were approximately €3.5 million for the nine months ended September 30, 2019, compared to approximately €2.6 million for the nine months ended September 30, 2018. The increase in project development costs is mainly attributable to consultancy expenses in connection with the project to construct a 156 MW pumped storage hydro power plant in the Manara Cliff, Israel.
      • General and administrative expenses were approximately €2.9 million for the nine months ended September 30, 2019, compared to approximately €2.8 million for the nine months ended September 30, 2018.
      • Company's share of profits of equity accounted investee, after elimination of intercompany transactions, was approximately €2.4 million for the nine months ended September 30, 2019, compared to approximately €2.2 million in the nine months ended September 30, 2018.
      • Financing expenses, net was approximately €4.6 million for the nine months ended September 30, 2019, compared to approximately €1.8 million for the nine months ended September 30, 2018. The increase in financing expenses was mainly due to expenses in connection with exchange rate differences amounting to approximately €2.1 million in the nine months ended September 30, 2019, mainly in connection with the Company's NIS denominated Debentures, the loan to an equity accounted investee and cash and cash equivalents, caused by the 11.3% devaluation of the euro against the NIS during this period, compared to income in connection with exchange rate differences amounting to approximately €0.5 million in the nine months ended September 30, 2018, caused by the 1.5% revaluation of the euro against the NIS during this period.
      • Taxes on income was approximately €0.9 million for the nine months ended September 30, 2019, compared to taxes on income of approximately €0.1 million for the nine months ended September 30, 2018. The lower taxes on income for the nine months ended September 30, 2018 resulted mainly from deferred tax income included in connection with the application of a tax incentive in the Netherlands claimable upon filing the relevant tax return by reducing the amount of taxable profit.
      • Net loss was approximately €3.8 million for the nine months ended September 30, 2019, compared to approximately €0.1 million for the nine months ended September 30, 2018.
      • Total other comprehensive income was approximately €13.8 million for the nine months ended September 30, 2019, compared to a loss of approximately €0.8 million for the nine months ended September 30, 2018. The change was mainly due to changes in fair value of cash flow hedges and from foreign currency translation differences on New Israeli Shekel denominated operations, as a result of fluctuations in the euro/NIS exchange rates.
      • Total comprehensive income was approximately €10 million for the nine months ended September 30, 2019, compared to a loss of approximately €0.9 million for the nine months ended September 30, 2018.
      • EBITDA was approximately €6.4 million for the nine months ended September 30, 2019, compared to approximately €6.2 million for the nine months ended September 30, 2018.
      • Net cash from operating activities was approximately €4.3 million for the nine months ended September 30, 2019, compared to approximately €4.6 million for the nine months ended September 30, 2018.
      • On July 17, 2019, the Company issued 800,000 ordinary shares to several Israeli classified investors in a private placement. The price per share in the Private Placement was set at NIS 39.20 (approximately $11) and the gross proceeds to the Company were approximately NIS 31.3 million (approximately €7.8 million).
      • On July 25, 2019, the Company issued NIS 89,065,000 (approximately €22.7 million) Series C Debentures in a public offering in Israel at a fixed annual interest rate of 3.3%. The net proceeds of the offering, net of related expenses such as consultancy fee and commissions were approximately NIS 87.8 million (approximately €22.3 million).
      • During July 2019, the Company completed the purchase of 49% of the companies that own the anaerobic digestion plans in Goor and Oude-Tonge, both in the Netherlands from Ludan and several entities affiliated with Ludan for an acquisition price of approximately €3 million.
      • On December 16, 2019, the Company announced its intention to redeem the entire outstanding principal of the Company's Series A Debentures. The redemption is scheduled for January 5, 2020. Pursuant to the terms of the deed of trust governing the Series A Debentures, the early redemption amount will be the sum of approximately NIS 80.1 million (approximately €20.7 million) in principal, the sum of approximately NIS 0.05 million (approximately €0.01 million) in accrued interest and a prepayment charge of approximately NIS 5.7 million (approximately €1.5 million), amounting to an aggregate redemption amount of approximately NIS 85.9 million (approximately €22.2 million, based on the exchange rate as of December 30, 2019).
      • On December 23, 2019, the Company reported the sale of ten Italian indirect wholly-owned subsidiaries (the "Italian Subsidiaries"), which own twelve photovoltaic plants with an aggregate nominal capacity of approximately 22.6 MW. The agreed purchase price was €41 million for the cutoff date of December 31, 2018 and adjusted in connection with funds received by the Company from the Italian Subsidiaries during 2019 (approximately €2.3 million), resulting in a cash purchase price of approximately €38.7 million. Based on the information currently available, the Company estimates that it will record a profit of approximately €19 million in connection with the sale of the Italian Subsidiaries in its financial results for the fourth quarter of 2019. The profit currently expected to be recorded is an unaudited and unreviewed estimate and the actual results may be different from this estimation. The financial results of the Company included in this release do not reflect the sale of the Italian Subsidiaries and therefore are not indicative of future results of the Company.
      • As of December 1, 2019, the Company held approximately €59.1 million in cash and cash equivalents, approximately €6.5 million in Short-term deposits, approximately €2.3 million in marketable securities and approximately €11.2 million in restricted short-term and long-term cash and marketable securities.

      Use of NON-IFRS Financial Measures

      EBITDA is a non-IFRS measure and is defined as earnings before financial expenses, net, taxes, depreciation and amortization. The Company presents this measure in order to enhance the understanding of the Company's historical financial performance and to enable comparability between periods. While the Company considers EBITDA to be an important measure of comparative operating performance, EBITDA should not be considered in isolation or as a substitute for net income or other statement of operations or cash flow data prepared in accordance with IFRS as a measure of profitability or liquidity. EBITDA does not take into account the Company's commitments, including capital expenditures, and restricted cash and, accordingly, is not necessarily indicative of amounts that may be available for discretionary uses. Not all companies calculate EBITDA in the same manner, and the measure as presented may not be comparable to similarly-titled measures presented by other companies. The Company's EBITDA may not be indicative of the historic operating results of the Company; nor is it meant to be predictive of potential future results. A reconciliation between results on an IFRS and non-IFRS basis is provided in the last table of this press release.

      About Ellomay Capital Ltd.

      Ellomay is an Israeli based company whose shares are registered with the NYSE American and with the Tel Aviv Stock Exchange under the trading symbol "ELLO". Since 2009, Ellomay Capital focuses its business in the renewable energy and power sectors in Europe and Israel.

      To date, Ellomay has evaluated numerous opportunities and invested significant funds in the renewable, clean energy and natural resources industries in Israel, Italy and Spain, including:

      • Approximately 7.9MW of photovoltaic power plants in Spain and a photovoltaic power plant of approximately 9 MW in Israel;
      • 9.375% indirect interest in Dorad Energy Ltd., which owns and operates one of Israel's largest private power plants with production capacity of approximately 850MW, representing about 6%-8% of Israel's total current electricity consumption;
      • 51% of Talasol, which is involved in a project to construct a photovoltaic plant with a peak capacity of 300MW in the municipality of Talaván, Cáceres, Spain;
      • 100% of Groen Gas Goor B.V. and of Groen Gas Oude-Tonge B.V., project companies developing anaerobic digestion plants with a green gas production capacity of approximately 375 Nm3/h, in Goor, the Netherlands and 475 Nm3/h, in Oude Tonge, the Netherlands, respectively;
      • 75% of Chashgal Elyon Ltd., Agira Sheuva Electra, L.P. and Ellomay Pumped Storage (2014) Ltd., all of which are involved in a project to construct a 156 MW pumped storage hydro power plant in the Manara Cliff, Israel.

      Ellomay Capital is controlled by Mr. Shlomo Nehama, Mr. Hemi Raphael and Mr. Ran Fridrich. Mr. Nehama is one of Israel's prominent businessmen and the former Chairman of Israel's leading bank, Bank Hapohalim, and Messrs. Raphael and Fridrich both have vast experience in financial and industrial businesses. These controlling shareholders, along with Ellomay's dedicated professional management, accumulated extensive experience in recognizing suitable business opportunities worldwide. Ellomay believes the expertise of Ellomay's controlling shareholders and management enables the Company to access the capital markets, as well as assemble global institutional investors and other potential partners. As a result, we believe Ellomay is capable of considering significant and complex transactions, beyond its immediate financial resources.

      For more information about Ellomay, visit http://www.ellomay.com.

      Information Relating to Forward-Looking Statements

      This press release contains forward-looking statements that involve substantial risks and uncertainties, including statements that are based on the current expectations and assumptions of the Company's management. All statements, other than statements of historical facts, included in this press release regarding the Company's plans and objectives, expectations and assumptions of management are forward-looking statements.  The use of certain words, including the words "estimate," "project," "intend," "expect," "believe" and similar expressions are intended to identify forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.  The Company may not actually achieve the plans, intentions or expectations disclosed in the forward-looking statements and you should not place undue reliance on the Company's forward-looking statements. Various important factors could cause actual results or events to differ materially from those that may be expressed or implied by the Company's forward-looking statements, including weather conditions, regulatory changes, changes in the supply and prices of resources required for the operation of the Company's facilities (such as waste and natural gas), changes in demand and technical and other disruptions in the operations or construction of the power plants owned by the Company. These and other risks and uncertainties associated with the Company's business are described in greater detail in the filings the Company makes from time to time with Securities and Exchange Commission, including its Annual Report on Form 20-F. The forward-looking statements are made as of this date and the Company does not undertake any obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise.

      Contact:
      Kalia Weintraub
      CFO
      Tel: +972 (3) 797-1111
      Email: [email protected]

      Ellomay Capital Ltd. and its Subsidiaries

      Condensed Consolidated Statements of Financial Position



      December 31,

      September 30,

      September 30,



      2018

      2019

      2019



      Audited

      Unaudited

      Unaudited



      € in thousands

      Convenience Translation
      into US$ in thousands

      Assets





      Current assets





      Cash and cash equivalents


      36,882

      70,808

      77,376

      Marketable securities


      2,132

      2,303

      2,517

      Short term deposits


      -

      6,570

      7,179

      Restricted cash and marketable securities


      4,653

      15

      16

      Receivable from concession project


      1,292

      1,498

      1,637

      Financial assets


      1,282

      1,445

      1,579

      Trade and other receivables


      12,623

      10,239

      11,189



      58,864

      92,878

      101,493

      Non-current assets





      Investment in equity accounted investee


      27,746

      33,391

      36,488

      Advances on account of investments


      798

      900

      983

      Receivable from concession project


      25,710

      27,891

      30,478

      Fixed assets


      87,220

      138,574

      151,429

      Right-of-use asset


      -

      4,165

      4,551

      Intangible asset


      4,882

      5,231

      5,716

      Restricted cash and deposits


      2,062

      11,226

      12,267

      Deferred tax


      2,423

      2,477

      2,707

      Long term receivables


      1,455

      1,674

      1,829

      Derivatives


      -

      23,966

      26,189



      152,296

      249,495

      272,637

      Total assets


      211,160

      342,373

      374,130






      Liabilities and Equity





      Current liabilities





      Current maturities of long term loans


      5,864

      7,051

      7,705

      Debentures


      8,758

      9,963

      10,887

      Trade payables


      2,126

      2,540

      2,773

      Other payables


      3,103

      4,610

      5,038



      19,851

      24,164

      26,403

      Non-current liabilities





      Lease liability


      -

      3,987

      4,357

      Long-term loans


      60,228

      118,262

      129,232

      Debentures


      42,585

      66,495

      72,663

      Deferred tax


      6,219

      10,471

      11,442

      Other long-term liabilities


      228

      27

      30

      Derivatives


      5,092

      12,437

      13,591



      114,352

      211,679

      231,315

      Total liabilities


      134,203

      235,843

      257,718






      Equity





      Share capital


      19,980

      21,998

      24,039

      Share premium


      58,344

      64,155

      70,106

      Treasury shares


      (1,736)

      (1,736)

      (1,897)

      Transaction reserve with non-controlling Interests


      -

      6,106

      6,672

      Reserves


      1,169

      9,569

      10,457

      Retained earnings (accumulated deficit)


      758

      (865)

      (945)

      Total equity attributed to shareholders of the Company


      78,515

      99,227

      108,432

      Non-Controlling Interest


      (1,558)

      7,303

      7,980

      Total equity


      76,957

      106,530

      116,412

      Total liabilities and equity


      211,160

      342,373

      374,130


      * Convenience translation into US$ (exchange rate as at September 30, 2019: euro 1 = US$ 1.093)

       

      Ellomay Capital Ltd. and its Subsidiaries

      Condensed Consolidated Statements of Comprehensive Income (in thousands, except per share data)


      For the year ended December 31,

      For the three months
      ended September 30,

      For the nine months
      ended September 30

      For the nine months
      ended  September 30,


      2018

      2018

      2019

      2018

      2019

      2019


      Audited

      Unaudited

      Unaudited

      Unaudited


       

      € in thousands

       

      € in thousands

       

      € in thousands

      Convenience
      Translation into US$*

      Revenues

      18,117

      5,720

      5,132

      13,871

      15,435

      16,867

      Operating expenses

      (6,342)

      (1,963)

      (1,594)

      (4,573)

      (5,049)

      (5,517)

      Depreciation expenses

      (5,816)

      (1,597)

      (1,671)

      (4,364)

      (4,714)

      (5,151)

      Gross profit

      5,959

      2,160

      1,867

      4,934

      5,672

      6,199








      Project development costs

      (2,878)

      (851)

      (757)

      (2,622)

      (3,471)

      (3,793)

      General and administrative expenses

      (3,600)

      (785)

      (979)

      (2,762)

      (2,858)

      (3,123)

      Share of profits of equity accounted investee

      2,545

      1,713

      2,351

      2,214

      2,382

      2,603

      Other income, net

      884

      -

      -

      73

      -

      -

      Operating profit

      2,910

      2,237

      2,482

      1,837

      1,725

      1,886








      Financing income

      2,936

      518

      572

      1,857

      1,442

      1,576

      Financing income (expenses) in connection with derivatives and other assets, net

      494

      31

      535

      316

      995

      1,087

      Financing expenses

      (5,521)

      (1,468)

      (2,592)

      (4,008)

      (7,049)

      (7,703)

      Financing expenses, net

      (2,091)

      (919)

      (1,485)

      (1,835)

      (4,612)

      (5,040)








      Profit (loss) before taxes on income

      819

      1,318

      997

      2

      (2,887)

      (3,154)








      Taxes on income

      (215)

      (302)

      (399)

      (120)

      (913)

      (998)








      Profit (loss) for the period

      604

      1,016

      598

      (118)

      (3,800)

      (4,152)

      Profit (loss) attributable to:







      Owners of the Company

      1,057

      1,282

      1,128

      384

      (1,623)

      (1,773)

      Non-controlling interests

      (453)

      (266)

      (530)

      (502)

      (2,177)

      (2,379)

      Profit (loss) for the period

      604

      1,016

      598

      (118)

      (3,800)

      (4,152)

      Other comprehensive income (loss) items that after







      initial recognition in comprehensive income (loss)







      were or will be transferred to profit or loss:







      Foreign currency translation differences for foreign operations

      (787)

      270

      8,129

      (529)

      9,111

      9,956








      Effective portion of change in fair value of cash flow hedges

      (1,008)

      192

      7,345

      (532)

      6,977

      7,624

      Net change in fair value of cash flow hedges transferred to
      profit or loss

       

      643

       

      (183)

       

      (1,174)

       

      295

       

      (2,278)

       

      (2,489)

      Total other comprehensive income (loss)

      (1,152)

      279

      14,300

      (766)

      13,810

      15,091

      Total comprehensive income (loss) for the period 

      (548)

      1,295

      14,898

      (884)

      10,010

      10,939








      Basic net income (loss) per share

      0.10

      0.12

      0.10

      0.04

      (0.14)

      (0.16)

      Diluted net income (loss) per share

      0.10

      0.12

      0.10

      0.04

      (0.14)

      (0.16)


      * Convenience translation into US$ (exchange rate as at September 30, 2019: euro 1 = US$ 1.093)


      Ellomay Capital Ltd. and its Subsidiaries

      Condensed Consolidated Statements of Changes in Equity (in thousands)

      Attributable to shareholders of the Company

      Non-controlling Interests

      Total
      Equity


      Share capital

      Share Premium

      Retained earnings (accumulated deficit)

      Treasury shares

      Translation reserve from foreign operations

      Hedging Reserve

      Transaction reserve with non-controlling Interests

      Total





      € in thousands

      For the nine months ended September 30,
      2019:











      Balance as at January 1, 2019

      19,980

      58,344

      758

      (1,736)

      1,396

      (227)

      -

      78,515

      (1,558)

      76,957

      Loss for the period

      -

      -

      (1,623)

      -

      -

      -

      -

      (1,623)

      (2,177)

      (3,800)

      Other comprehensive loss for the period

      -

      -

      -

      -

      3,701

      4,699

      -

      8,400

      5,410

      13,810

      Total comprehensive loss for the period

      -

      -

      (1,623)

      -

      3,701

      4,699

      -

      6,777

      3,233

      10,010












      Transactions with owners of the











       Company, recognized directly in equity:











      Sale of shares in subsidiaries to











      non-controlling interests

      -

      -

      -

      -

      -

      -

      5,439

      5,439

      5,374

      10,813

      Buy of shares in subsidiaries from











      non-controlling interests

      -

      -

      -

      -

      -

      -

      667

      667

      254

      921

      Issuance of ordinary shares

      2,010

      5,797

      -

      -

      -

      -

      -

      7,807

      -

      7,807

      Options exercise

      8

      11

      -

      -

      -

      -

      -

      19

      -

      19

      Share-based payments

      -

      3

      -

      -

      -

      -

      -

      3

      -

      3












      Balance as at September 30, 2019

      21,998

      64,155

      (865)

      (1,736)

      5,097

      4,472

      6,106

      99,227

      7,303

      106,530

      Ellomay Capital Ltd. and its Subsidiaries

      Condensed Consolidated Interim Statements of Changes in Equity (in thousands) (cont'd)




      Attributable to shareholders of the Company

      Non-controlling

      Interests

      Total

      Equity


      Share

      capital

      Share

      Premium

      Retained

      earnings

      (accumulated

      deficit)

      Treasury

      Shares

      Translation

      reserve from

      Foreign

      operations

      Hedging

      Reserve

      Transaction

      reserve with

      non-controlling

      Interests

      Total





      US$ in thousands*

      For the nine months ended September 30, 2019:











      Balance as at January 1, 2019

      21,834

      63,756

      828

      (1,897)

      1,526

      (248)

      -

      85,799

      (1,704)

      84,095

      Loss for the period

      -

      -

      (1,773)

      -

      -

      -

      -

      (1,773)

      (2,379)

      (4,152)

      Other comprehensive loss for the period

      -

      -

      -

      -

      4,044

      5,135

      -

      9,179

      5,912

      15,091

      Total comprehensive loss for the period

      -

      -

      (1,773)

      -

      4,044

      5,135

      -

      7,406

      3,533

      10,939












      Transactions with owners of the











       Company, recognized directly in equity:











      Sale of shares in subsidiaries to











      non-controlling interests

      -

      -

      -

      -

      -

      -

      5,943

      5,943

      5,873

      11,816

      Buy of shares in subsidiaries from











      non-controlling interests

      -

      -

      -

      -

      -

      -

      729

      729

      278

      1,007

      Issuance of ordinary shares

      2,196

      6,335

      -

      -

      -

      -

      -

      8,531

      -

      8,531

      Options exercise

      9

      12

      -

      -

      -

      -

      -

      21

      -

      21

      Share-based payments

      -

      3

      -

      -

      -

      -

      -

      3

      -

      3












      Balance as at September 30, 2019

      24,039

      70,106

      (945)

      (1,897)

      5,570

      4,887

      6,672

      108,432

      7,980

      116,412


      * Convenience translation into US$ (exchange rate as at September 30, 2019: euro 1 = US$ 1.093)

      Ellomay Capital Ltd. and its Subsidiaries


      Condensed Consolidated Interim Statements of Changes in Equity (in thousands) (cont'd)











      Non-











      controlling

      Total


      Attributable to shareholders of the Company

      Interests

      Equity




      Retained


      Translation


      Transaction







      earnings


      reserve from


      reserve with





      Share

      Share

      (accumulated

      Treasury

      foreign

      Hedging

      non-controlling





      capital

      Premium

      deficit)

      shares

      operations

      Reserve

      Interests

      Total





      € in thousands

      For the three months ended September 30,
      2019:











      Balance as at June 30, 2019

      19,988

      58,358

      (1,993)

      (1,736)

      2,855

      (1,699)

      5,614

      81,387

      1,217

      82,604

      Loss for the period

      -

      -

      1,128

      -

      -

      -

      -

      1,128

      (530)

      598

      Other comprehensive loss for the period

      -

      -

      -

      -

      2,242

      6,171

      -

      8,413

      5,887

      14,300

      Total comprehensive loss for the period

      -

      -

      1,128

      -

      2,242

      6,171

      -

      9,541

      5,357

      14,898












      Transactions with owners of the











       Company, recognized directly in equity:











      Sale of shares in subsidiaries to











      non-controlling interests

      -

      -

      -

      -

      -

      -

      (175)

      (175)

      475

      300

      Buy of shares in subsidiaries from











      non-controlling interests

      -

      -

      -

      -

      -

      -

      667

      667

      254

      921

      Issuance of ordinary shares

      2,010

      5,797

      -

      -

      -

      -

      -

      7,807

      -

      7,807

      Options exercise

      -

      -

      -

      -

      -

      -

      -

      -

      -

      -

      Share-based payments

      -

      -

      -

      -

      -

      -

      -

      -

      -

      -












      Balance as at September 30, 2019

      21,998

      64,155

      (865)

      (1,736)

      5,097

      4,472

      6,106

      99,227

      7,303

      106,530

      Ellomay Capital Ltd. and its Subsidiaries


      Condensed Consolidated Interim Statements of Changes in Equity (in thousands) (cont'd)










      Non-










      controlling

      Total



      Attributable to shareholders of the Company

      Interests

      Equity




      Retained


      Translation








      earnings


      reserve from






      Share

      Share

      (accumulated

      Treasury

      foreign

      Hedging





      capital

      Premium

      deficit)

      shares

      operations

      Reserve

      Total




      € in thousands











      For the nine months ended September 30, 2018:










      Balance as at January 1, 2018

      19,980

      58,339

      (299)

      (1,736)

      2,219

      138

      78,641

      (1,141)

      77,500

      Loss for the period

      -

      -

      384

      -

      -

      -

      384

      (502)

      (118)

      Other comprehensive loss for the period

      -

      -

      -

      -

      (540)

      (237)

      (777)

      11

      (766)

      Total comprehensive loss for the period

      -

      -

      384

      -

      (540)

      (237)

      (393)

      (491)

      (884)











      Transactions with owners of the Company,










       recognized directly in equity:










      Share-based payments

      -

      3

      -

      -

      -

      -

      3

      -

      3











      Balance as at September 30, 2018

      19,980

      58,342

      85

      (1,736)

      1,679

      (99)

      78,251

      (1,632)

      76,619

       

      Ellomay Capital Ltd. and its Subsidiaries


      Condensed Consolidated Interim Statements of Changes in Equity (in thousands) (cont'd)










      Non-










      controlling

      Total



      Attributable to shareholders of the Company

      Interests

      Equity




      Retained


      Translation








      earnings


      reserve from






      Share

      Share

      (accumulated

      Treasury

      foreign

      Hedging





      capital

      Premium

      deficit)

      shares

      operations

      Reserve

      Total




      € in thousands











      For the three months ended September 30, 2018:










      Balance as at June 30, 2018

      19,980

      58,341

      (1,197)

      (1,736)

      1,397

      (108)

      76,677

      (1,354)

      75,323

      Loss for the period

      -

      -

      1,282

      -

      -

      -

      1,282

      (266)

      1,016

      Other comprehensive loss for the period

      -

      -

      -

      -

      282

      9

      291

      (12)

      279

      Total comprehensive loss for the period

      -

      -

      1,282

      -

      282

      9

      1,573

      (278)

      1,295











      Transactions with owners of the Company,










       recognized directly in equity:










      Share-based payments

      -

      1

      -

      -

      -

      -

      1

      -

      1











      Balance as at September 30, 2018

      19,980

      58,342

      85

      (1,736)

      1,679

      (99)

      78,251

      (1,632)

      76,619

      Ellomay Capital Ltd. and its Subsidiaries


      Condensed Consolidated Interim Statements of Changes in Equity (in thousands) (cont'd)










      Non-










      controlling

      Total



      Attributable to shareholders of the Company

      Interests

      Equity




      Retained


      Translation








      earnings


      reserve from






      Share

      Share

      (accumulated

      Treasury

      foreign

      Hedging





      capital

      premium

      deficit)

      shares

      operations

      Reserve

      Total




      € in thousands











      For the year ended December 31, 2018:




















      Balance as at January 1, 2018

      19,980

      58,339

      (299)

      (1,736)

      2,219

      138

      78,641

      (1,141)

      77,500

      Profit for the year

      -

      -

      1,057

      -

      -

      -

      1,057

      (453)

      604

      Other comprehensive income (loss) for the year

      -

      -

      -

      -

      (823)

      (365)

      (1,188)

      36

      (1,152)

      Total comprehensive income (loss) for the year

      -

      -

      1,057

      -

      (823)

      (365)

      (131)

      (417)

      (548)











      Transactions with owners of the










       Company, recognized directly in equity:










      Share-based payments

      -

      5

      -

      -

      -

      -

      5

      -

      5











      Balance as at December 31, 2018

      19,980

      58,344

      758

      (1,736)

      1,396

      (227)

      78,515

      (1,558)

      76,957

       

      Ellomay Capital Ltd. and its Subsidiaries


      Condensed Consolidated Interim Statements of Cash Flow (in thousands)


      For the year ended December 31,

      For the three months ended September 30,

      For the nine months ended September 30,

      For the nine months ended September 30, 2019


      2018

      2018

      2019

      2018

      2019

      2019


      Audited

      Unaudited

      Unaudited

      Unaudited


       

      € in thousands

      Convenience Translation
      into US$*

      Cash flows from operating activities







      Profit (loss) for the period

      604

      1,016

      598

      (118)

      (3,800)

      (4,152)

      Adjustments for:







      Financing expenses, net

      2,091

      919

      1,485

      1,835

      4,612

      5,040

      Depreciation

      5,816

      1,597

      1,671

      4,364

      4,714

      5,151

      Share-based payment transactions

      5

      1

      -

      3

      3

      3

      Share of profits of equity accounted investees 

      (2,545)

      (1,713)

      (2,351)

      (2,214)

      (2,382)

      (2,603)

      Payment of interest on loan from an equity accounted investee

      3,036

      -

      -

      1,176

      370

      404

      Change in trade receivables and other receivables

      (17)

      (356)

      842

      (200)

      (902)

      (986)

      Change in other assets

      37

      (355)

      (762)

      (220)

      (1,470)

      (1,606)

      Change in receivables from concessions project

      1,431

      454

      483

      1,076

      1,129

      1,234

      Change in accrued severance pay, net

      15

      (2)

      -

      15

      8

      9

      Change in trade payables

      633

      (37)

      (651)

      291

      414

      452

      Change in other payables

      (1,565)

      271

      1,636

      (39)

      2,690

      2,939

      Taxes on income

      215

      302

      399

      120

      913

      998

      Income taxes paid

      (77)

      (28)

      (19)

      (44)

      (19)

      (21)

      Interest received

      1,835

      518

      446

      1,406

      1,281

      1,400

      Interest paid

      (4,924)

      (206)

      (582)

      (2,803)

      (3,237)

      (3,537)

      Net cash provided by operating activities

      6,590

      2,381

      3,195

      4,648

      4,324

      4,725








      Cash flows from investing activities







      Acquisition of fixed assets

      (3,708)

      (455)

      (11,316)

      (3,061)

      (55,835)

      (61,014)

      Acquisition of subsidiary, net of cash acquired

      (1,000)

      -

      -

      -

      (1,000)

      (1,093)

      Repayment of loan from an equity accounted investee

      1,540

      -

      -

      490

      -

      -

      Proceeds from marketable securities

      3,316

      3,316

      -

      3,316

      -

      -

      Proceed from settlement of derivatives, net

      664

      187

      -

      410

      532

      581

      Proceed (investment) in restricted cash, net

      (3,107)

      (3,393)

      1,356

      (1,789)

      (3,863)

      (4,221)

      Investment in short term deposit

      -

      -

      (6,302)

      -

      (6,302)

      (6,887)

      Repayment (grant) Loan to others

      (3,500)

      -

      412

      -

      3,912

      4,275

      Net cash used in investing activities

      (5,795)

      (345)

      (15,850)

      (634)

      (62,556)

      (68,359)








      Cash flows from financing activities







      Repayment of long-term loans and finance lease obligations

      (17,819)

      (201)

      (252)

      (14,928)

      (4,410)

      (4,819)

      Repayment of Debentures

      (4,668)

      -

      -

      -

      (4,532)

      (4,952)

      Proceeds from options

      -

      -

      -

      -

      19

      21

      Sale of shares in subsidiaries to non-controlling interests

      -

      -

      (126)

      -

      13,936

      15,229

      Acquisition of shares in subsidiaries from non-controlling interests

      -

      -

      (2,961)

      -

      (2,961)

      (3,236)

      Issuance of ordinary shares

      -

      -

      7,807

      -

      7,807

      8,531

      Proceeds from issuance of Debentures, net

      -

      -

      22,317

      -

      22,317

      24,387

      Proceeds from long term loans, net

      34,745

      14

      192

      34,515

      59,086

      64,567

      Net cash provided by (used in) financing activities

      12,258

      (187)

      26,977

      19,587

      91,262

      99,728








      Effect of exchange rate fluctuations on cash and cash equivalents

      (133)

      (73)

      951

      (177)

      896

      979

      Increase in cash and cash equivalents

      12,920

      1,776

      15,273

      23,424

      33,926

      37,073

      Cash and cash equivalents at the beginning of the period

      23,962

      45,610

      55,535

      23,962

      36,882

      40,303

      Cash and cash equivalents at the end of the period

      36,882

      47,386

      70,808

      47,386

      70,808

      77,376

      * Convenience translation into US$ (exchange rate as at September 30, 2019: euro 1 = US$ 1.093)

      Ellomay Capital Ltd. and its Subsidiaries


      Reconciliation of Net Profit (Loss) to EBITDA (in thousands)



      For the year
      ended
      December 31,

      For the three months
      ended September 30,

      For the nine months
      ended September 30,

      For the nine
      months ended
      September 30,


      2018

      2018

      2019

      2018

      2019

      2019


      Unaudited


       

      € in thousands

      Convenience
      Translation into US$*

      Net Profit (loss) for the period

      604

      1,016

      598

      (118)

      (3,800)

      (4,152)

      Financing expenses, net

      2,091

      919

      1,485

      1,835

      4,612

      5,040

      Taxes on income

      215

      302

      399

      120

      913

      998

      Depreciation

      5,816

      1,597

      1,671

      4,364

      4,714

      5,151

      EBITDA

      8,726

      3,834

      4,153

      6,201

      6,439

      7,037

      * Convenience translation into US$ (exchange rate as at September 30, 2019: euro 1 = US$ 1.093)

       

      Information for the Company's Debenture Holders

      Pursuant to the Deeds of Trust governing the Company's Series A, B and C Debentures (together, the "Debentures"), the Company is required to maintain certain financial covenants. For more information, see Item 5.B of the Company's Annual Report on Form 20-F and "Liquidity and Capital Resources" under Exhibit 99.3 of a Form 6-K submitted to the Securities and Exchange Commission on September 25, 2019.

      Net Financial Debt

      As of September 30, 2019, the Company's Net Financial Debt (as such term is defined in the Deeds of Trust of the Company's Debentures) was approximately €43.8 million (consisting of approximately €135.4 million of short-term and long-term debt from banks and other interest bearing financial obligations and approximately €76.5 million in connection with the Series A Debentures issuances (in January and September 2014), the Series B Debentures issuance (in March 2017) and the Series C Debentures issuance (in July 2019), net of approximately €79.7 million of cash and cash equivalents, short-term deposits and marketable securities and net of approximately €88.7 million of project finance and related hedging transactions of the Company's subsidiaries).

      Information for the Company's Series B Debenture Holders

      The following is an internal pro forma consolidated statement of financial position of the Company as at September 30, 2019. This information is required under the Series B Deed of Trust in connection with the adoption of IFRS 16 "Leases" by the Company and provides the consolidated statement of financial position of the Company as of the date set forth below after elimination of the effects of adoption of IFRS 16. Based on the pro forma statement of financial position, the ratio of the Company's equity (which the Company calculated in line with the definition of Balance Sheet Equity in the Series B Deed of Trust)  to balance sheet as at June 30, 2019 was 29.2%, triggering a right of the holders of our Series B Debentures to an increase in the annual interest rate applicable to the Series B Debentures of 0.5% until such time as we publish financial results reflecting an increase in such ratio to a minimum of 30%. Based on the pro forma statement of financial position, the ratio of the Company's equity, as set forth above, to balance sheet as of September 30, 2019 was 31.6%, triggering a decrease in the annual interest rate applicable to the Series B Debentures of 0.5% to its original rate of 3.69%. The Company will provide further information concerning the updated interest rate in a Form 6-K to be furnished to the Securities and Exchange Commission.

      Unaudited Internal Pro Forma Statement of Financial Position

       



      September 30,



      2019



      Unaudited



      Pro Forma

      € in thousands

      Assets



      Current assets



      Cash and cash equivalents


      70,808

      Marketable securities


      2,303

      Short term deposits


      6,570

      Restricted cash and marketable securities


      15

      Receivable from concession project


      1,498

      Financial assets


      1,445

      Trade and other receivables


      10,239



      92,878

      Non-current assets



      Investment in equity accounted investee


      33,391

      Advances on account of investments


      900

      Receivable from concession project


      27,891

      Fixed assets


      138,574

      Right-of-use asset


      -

      Intangible asset


      5,231

      Restricted cash and deposits


      11,226

      Deferred tax


      1,423

      Long term receivables


      1,674

      Derivatives


      23,966



      244,276

      Total assets


      337,154




      Liabilities and Equity



      Current liabilities



      Current maturities of long term loans


      7,051

      Debentures


      9,963

      Trade payables


      2,540

      Other payables


      4,382



      23,936

      Non-current liabilities



      Lease liability


      -

      Long-term loans


      118,262

      Debentures


      66,495

      Deferred tax


      9,430

      Other long-term liabilities


      27

      Derivatives


      12,437



      206,651

      Total liabilities


      230,587




      Equity



      Share capital


      21,998

      Share premium


      64,155

      Treasury shares


      (1,736)

      Transaction reserve with non-controlling Interests


      6,106

      Reserves


      9,569

      Accumulated deficit


      (828)

      Total equity attributed to shareholders of the Company


      99,264

      Non-Controlling Interest


      7,303

      Total equity


      106,567

      Total liabilities and equity


      337,154

      Information for the Company's Series C Debenture Holders

      The Deed of Trust governing the Company's Series C Debentures includes an undertaking by the Company to maintain certain financial covenants, whereby a breach of such financial covenants for two consecutive quarters is a cause for immediate repayment. As of September 30, 2019, the Company was in compliance with the financial covenants set forth in the Series C Deed of Trust as follows: (i) the Company's shareholders' equity was €106.5 million, (ii) the ratio of the Company's Net Financial Debt (as set forth above) to the Company's CAP, Net (defined as the Company's consolidated shareholders' equity plus the Net Financial Debt was 29% and (iii) the ratio of the Company's Net Financial Debt to the Company's Adjusted EBITDA(1) was 3.7.

      _____________________________

      (1) The term "Adjusted EBITDA" is defined in the Series C Deed of Trust as earnings before financial expenses, net, taxes, depreciation and amortization, where the revenues from the Company's operations, such as the Talmei Yosef project, are calculated based on the fixed asset model and not based on the financial asset model (IFRIC 12), and before share-based payments. The Series C Deed of Trust provides that for purposes of the financial covenant, the Adjusted EBITDA will be calculated based on the four preceding quarters, in the aggregate. The Adjusted EBITDA is presented in this press release as part of the Company's undertakings towards the holders of its Series C Debentures. For a general discussion of the use of non-IFRS measures, such as EBITDA and Adjusted EBITDA see above under "Use of NON-IFRS Financial Measures."

      The following is a reconciliation between the Company's net profit (loss) and the Adjusted EBITDA for the four-quarter period ended September 30, 2019:


      For the four
      quarter period
      ended
      September 30,
      2019


      Unaudited


      € in thousands

      Net loss for the period

      (3,078)

      Financing expenses, net

      4,868

      Taxes on income

      1,008

      Depreciation

      6,166

      Adjustment to revenues of the Talmei Yosef project due to calculation based on the fixed asset model

       

      2,883

      Share-based payments

      4

      Adjusted EBITDA as defined the Series C Deed of Trust

      11,851

      SOURCE Ellomay Capital Ltd

      Modal title

      Contact PR Newswire

      • Call PR Newswire at 888-776-0942
        from 8 AM - 9 PM ET
      • Chat with an Expert
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices

      Products

      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content

      About

      • About PR Newswire
      • About Cision
      • Careers
      • Accessibility Statement
      • APAC
      • APAC - Simplified Chinese
      • APAC - Traditional Chinese
      • Brazil
      • Canada
      • Czech
      • Denmark
      • Finland
      • France
      • Germany
      • India
      • Indonesia
      • Israel
      • Italy
      • Japan
      • Korea
      • Mexico
      • Middle East
      • Middle East - Arabic
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United Kingdom
      • Vietnam

      My Services

      • All New Releases
      • Platform Login
      • Data Privacy

      Do not sell or share my personal information:

      • Submit via [email protected] 
      • Call Privacy toll-free: 877-297-8921

      Contact PR Newswire

      Products

      About

      My Services
      • All News Releases
      • Platform Login
      • ProfNet
      Call PR Newswire at
      888-776-0942
      • Terms of Use
      • Privacy Policy
      • Information Security Policy
      • Site Map
      • RSS
      • Cookies
      Copyright © 2026 Cision US Inc.